UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis
NCT00638469
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
RADIATION:
UVB-311nm
OTHER:
No treatment
Sponsor
Medical University of Graz